Well said. I was in (and still remain) in MSL* pre and post RS and followed it from pennies to deep subpenny. The RS was the smartest thing they ever did. It got us out of subpenny gutter flippers, raised the pps, and attracted more respectable investors with a higher pps. The pps has never returned to subpenny equivalent levels and has only continued to rise. When news of RS was announced there, people were running for the hills and I was buying. Now those lots are close to 300% + up. The moral of the story is when a RS is done in the right setting for the right reasons, strategically, and if not followed by mass dilution (although MSL* still had a lot more dilution post RS and are still doing better then they ever have), it can actually be quite positive. No reason why PMBS won't turn out the same way, especially with a CBD product in the works which could easily be a huge catalyst...
PMBS
All of my posts are in my opinion only, formulated from the publicly available data and information, and are not meant to be investment advice in any shape or form...
